| Literature DB >> 34247264 |
Andre Shomorony1, Alexander Chern2, Sallie M Long2, Noah Z Feit2, Sarita S Ballakur2, Mariam Gadjiko2, Katie Liu2, Daniel A Skaf2, Andrew B Tassler2, Anthony P Sclafani2.
Abstract
PURPOSE: To identify areas of critical otolaryngology contributions to inpatient care resistant to disruption by the COVID-19 pandemic.Entities:
Keywords: COVID-19; Clinical research; Comprehensive otolaryngology; Inpatient consults; Tracheotomy
Mesh:
Year: 2021 PMID: 34247264 PMCID: PMC8272617 DOI: 10.1007/s00405-021-06963-7
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
General demographics and health status
| PRE-COVID-19 (Jan–Jun 2019, Jan–Feb 2020) | During COVID-19 (Mar–Jun 2020) | ||
|---|---|---|---|
| Total number of consults | 833 | 383 | – |
| Consults per month (mean ± SD) | 104.1 ± 8.6 | 95.8 ± 16.9 | 0.324 |
| Age, adults (mean ± SD) | 59.1 ± 3.1 | 60.9 ± 2.7 | 0.389 |
| Age, pediatric patients (mean ± SD) | 4.1 ± 1.3 | 2.7 ± 0.7 | 0.548 |
| Pediatric consults (%, mean ± SD) | 24.9 ± 5.7 | 11.9 ± 9.8 | 0.024 |
| Ratio M:F | 53:47 | 59:41 | – |
| SARS-CoV-2 positivity (%, mean ± SD) | 0 | 39.0 ± 30.4 | – |
| Intubationa (%, mean ± SD) | 8.0 ± 3.0 | 35.5 ± 30.3 | 0.022 |
| Anticoagulation (%, mean ± SD) | 8.8 ± 2.3 | 29.8 ± 13.3 | 0.003 |
| Renal replacement therapy (%, mean ± SD) | 2.6 ± 1.2 | 11.4 ± 6.5 | 0.003 |
Mean and standard deviation (SD) are calculated over the months indicated for each period, and % refers to percentage of consults per month
aPatients already intubated at the time of otolaryngology consult
Procedures performed before and during the COVID-19 pandemic
| PRE-COVID-19 (Jan–Jun 2019, Jan–Feb 2020) | During COVID-19 (Mar–Jun 2020) | ||
|---|---|---|---|
| Operative outcome by otolaryngology (% of consults, mean ± SD) | 17.3 ± 1.9 | 31.2 ± 21.0 | 0.122 |
| Bedside endoscopy (% of consults, mean ± SD) | 55.1 ± 6.1 | 29.7 ± 19.7 | 0.012 |
| Other bedside procedure (% of consults, mean ± SD) | 13.7 ± 3.8 | 14.4 ± 4.5 | 0.803 |
| Top five most common bedside procedures (average number per month) | Control of epistaxis (6.9) | Control of epistaxis (5.5) | – |
| Control of OC/OP bleeding (2.3) | Replacement of tracheostomy tube (2.5) | – | |
| NG tube placement (1.1) | Control of OC/OP bleeding (2.0) | – | |
| Repair of laceration (1.1) | Drainage of abscess (1.0) | – | |
| Replacement of tracheostomy tube (0.9) | Repair of laceration (0.8) | – |
Operative outcomes, bedside endoscopies and other bedside procedures do not overlap. The top five most common bedside procedures are expressed as average number of procedures per month, and are accounted for in ‘Other bedside procedure.’ Mean and standard deviation (SD) are calculated over the months indicated for each period, and % refers to percentage of consults per month. OC/OP, oral cavity/oropharynx; NG tube, nasogastric tube
Fig. 2Comparison of location of origin of consults before (Jan–Jun 2019, Jan–Feb 2020) and during (Mar–Jun 2020) the COVID-19 pandemic. Asterisk denotes p < 0.05
Fig. 4Airway consults. A Comparison of volume of tracheostomy-related consults before (Jan–Jun 2019, Jan–Feb 2020) and during (Mar–Jun 2020) the COVID-19 pandemic. Asterisk denotes p < 0.05. B Distribution of airway consults in SARS-CoV-2-positive patients during the pandemic
Fig. 5Comparison of top ten most common reasons for consult before (Jan–Jun 2019, Jan–Feb 2020) and during (Mar–Jun 2020) the COVID-19 pandemic in SARS-CoV-2-negative patients
Fig. 1Timeline of consult volume: absolute number of consults per month in the first 6 months of 2019 and 2020
Fig. 3Comparison of prevalence of consults before (Jan–Jun 2019, Jan–Feb 2020) and during (Mar–Jun 2020) the COVID-19 pandemic, organized by consult categories. Asterisk denotes p < 0.05